86.10.Z - Hospital activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
82.30.Z - Organisation of conventions and trade shows
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | -0,4 | 0,6 | 250,2 |
EBITDA | -0,2 | -0,4 | 0,7 | 294,9 |
Short time liabilities | 1 | 0,9 | 1,5 | 55,5 |
Equity capital | -0,3 | -0,3 | 0,3 | 200,3 |
Operating profit (EBIT) | -0,2 | -0,4 | 0,7 | 255,9 |
Assets | 0,7 | 0,6 | 1,8 | 190,8 |
Net profit (loss) | -0,2 | -0,4 | 0,6 | 250,2 |
Cash | 0,3 | 0,3 | 1,1 | 324,7 |
Liabilities and provisions for liabilities | 1 | 0,9 | 1,5 | 55,5 |
Net income from sale | 3,6 | 3,8 | 6 | 56,2 |
Working assets | 0,7 | 0,6 | 1,8 | 199,2 |
Depreciation | 0 | 0,1 | 0 | -80,1 |
% | % | % | p.p. | |
Profitability of capital | 64,9 | 133,4 | 199,7 | 66,3 |
Equity capital to total assets | -43,4 | -52,9 | 18,2 | 71,1 |
Gross profit margin | -5,3 | -11,3 | 10,8 | 22,1 |
EBITDA Margin | -5,1 | -9,2 | 11,5 | 20,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 99 | 89 | 89 | 0 |
Current financial liquidity indicator | 0.6971994042396545 | 0.6345802545547485 | 1.221397042274475 | 0,6 |
Net dept to EBITDA | 1.8633055686950684 | 0.7604429125785828 | -1.6573760509490967 | -2,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane